Results 101 to 110 of about 12,493 (244)

Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)

Journal of Blood Medicine, 2019
Madhvi Rajpurkar,1 Stacy E Croteau,2 Lisa Boggio,3 David L Cooper4 1Carman and Ann Adams Department of Pediatrics, Children’s Hospital of Michigan/Wayne State University, Detroit, MI, USA; 2Department of Pediatrics, Boston Children’s Hospital/
Rajpurkar M, Croteau SE, Boggio L, Cooper DL   +3 more
doaj  

Postmarketing surveillance [PDF]

BMJ, 1994
S, Voss, F, Harris
openaire   +2 more sources

Incentivizing the Utilization of Pharmacogenomics in Drug Development [PDF]

, 2012
Pharmacogenomics, the study and development of compounds according to how an individual’s genes affects the body’s response to drugs, holds enormous promise for increasing the safety and efficiency of drug development while decreasing adverse reactions ...
Koch, Valerie Gutmann
core   +1 more source

Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept [PDF]

, 2014
A patient affected by rheumatoid arthritis developed a squamous-cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to ...
Deidda, Arianna, Garau, Donatella, Longu, Maria Giovanna, Moretti, Grazia Maria Rita, Moretti, Mario Domenico Luigi, Pisanu, Claudia, Sanna, Maria Elena, Stochino, Maria Eminia   +7 more
core   +1 more source

Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope for the treatment of adult patients with growth hormone deficiency

Therapeutic Advances in Endocrinology and Metabolism, 2012
Objective : To describe the rationale and design of PATRO Adults, a postmarketing surveillance study of the long-term efficacy and safety of somatropin (Omnitrope ® ) for the treatment of adult patients with growth hormone deficiency (GHD).
Paolo Beck-Peccoz, Francesco Minuto, Alfonso Leal-Cerro, Markus Zabransky, Günter Stalla   +4 more
doaj   +1 more source

Using the Medical Research Council framework for the development and evaluation of complex interventions in a theory-based infant feeding intervention to prevent childhood obesity:The baby milk intervention and trial [PDF]

, 2014
Introduction. We describe our experience of using the Medical Research Council framework on complex interventions to guide the development and evaluation of an intervention to prevent obesity by modifying infant feeding behaviours. Methods.
Griffin, Simon, Hardeman, Wendy, Kinmonth, Ann Louise, Lakshman, Rajalakshmi, Ong, Ken K., Schiff, Annie   +5 more
core   +4 more sources

Comparing Claims Data to Stroke and Bleeding in the NCDR Left Atrial Appendage Occlusion Registry

JACC: Advances
Background: Claims data are increasingly used for postmarketing surveillance of therapies such as transcatheter left atrial appendage occlusion (LAAO), but their accuracy remains uncertain.
Kamil F. Faridi, MD, MSc, James V. Freeman, MD, MPH, MS, Yongfei Wang, MS, Lucy Pereira, BA, Sarah Zimmerman, MS, Daniel J. Friedman, MD, Richa Sharma, MD, MPH, Angela Y. Higgins, MD, Bobak J. Mortazavi, PhD, Joseph S. Ross, MD, MHS, Harlan M. Krumholz, MD, SM, Robert W. Yeh, MD, MSc, MD, MPH, Jeptha P. Curtis, MD   +12 more
doaj   +1 more source

Postmarketing Surveillance of the Safety of Cyclic Etidronate [PDF]

, 1998
Tjeerd van Staa, H.G.M. Leufkens, Lucien Abenhaim, Cyrus Cooper   +3 more
openalex   +1 more source

Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data [PDF]

, 2022
Hideki Terai, Kenzo Soejima, Asanao Shimokawa, Hidehito Horinouchi, Junichi Shimizu, Tetsunari Hase, Ryota Kanemaru, Kana Watanabe, Kiichiro Ninomiya, Naoko Sueoka‐Aragane, Noriko Yanagitani, Yoshihiko Sakata, Masahiro Seike, Daichi Fujimoto, Masashi Kasajima, Akihito Kubo, Sojiro Kusumoto, Yoshitaka Oyamada, Keiichi Fujiwara, Masahide Mori, Midori Hashimoto, Masato Shingyoji, Masahiro Kodani, Jin Sakamoto, Toshihiko Agatsuma, Kosuke Kashiwabara, Minehiko Inomata, Motoko Tachihara, Kazuhisa Tanaka, Kenji Hayashihara, Nobuyuki Koyama, Kaoru Matsui, Koichi Minato, Daisuke Jingu, Hiroyuki Sakashita, Satoshi Hara, Tomoyuki Naito, Asuka Okada, Masayuki Tanahashi, Yuki Sato, Koichiro Asano, Takayuki Takeda, Kensuke Nakazawa, Toshiyuki Harada, Kazuhiko Shibata, Tatsuo Kato, Etsuo Miyaoka, Ichiro Yoshino, Akihiko Gemma, Tetsuya Mitsudomi   +49 more
openalex   +1 more source

A Prospective, Multicenter Study on the Clinical Effectiveness and Safety of Abiraterone Plus Prednisone in Metastatic Hormone-Sensitive Prostate Cancer in Korea: Real-World Data Analysis [PDF]

Journal of Urologic Oncology
Purpose This postmarketing surveillance (PMS) study aimed to evaluate real-world data on the effectiveness and safety of abiraterone acetate plus prednisone (AAP) in patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Hyomyoung Lee, Seung-hwan Jeong, Sangeun Yeon, Youngdoe Kim, Jaeyoung Joung, Hanjong Ahn, Seongsoo Jeon, Hakmin Lee, Sangchul Lee, Choung-Soo Kim, Cheol Kwak   +10 more
doaj   +1 more source